Rho Chi Post

An award-winning, electronic, student-operated newsletter publication by the St. John's University College of Pharmacy and Health Sciences Rho Chi Beta Delta chapter

Menu

Skip to content
  • Home
  • Issues
    • Current Issue
    • All Issues
  • Articles
    • Featured
    • In the News / Politics
    • Events
    • Clinical
    • Advice / Opinions
    • Puzzles
    • Recently in PubMed
  • For Authors
    • Author Guidelines
    • AMA Citation Generator
    • Sign Up for Article(s)
    • Suggest Article(s)
    • Submit Article(s)
    • Check Statuses
    • Cite Your Article
  • About Us
    • About the Rho Chi Post
    • The Editorial Team
  • Apply for a Position
  • Subscribe
  • Login

June 2021

Connecting the Dots: Ankylosing Spondylitis and Heart D...
June 1, 2021 - Featured , In the News / Politics

By: Jennifer Galvet, PharmD Candidate c/o 2024              Ankylosing spondylitis (AS) is a systemic inflammatory condition that primarily affects a person’s back.¹ It is a form of arthritis that affects the spine and causes inflammation of the spinal joints, leading to severe, chronic pain and discomfort.² Ankylosing spondylitis can also impact other areas of the…

Correlation of Salt-Intake and Hypertension...
June 1, 2021 - Featured , In the News / Politics

By: Jordan Plair, PharmD Candidate c/o 2022 and Marina Beshara, PharmD Candidate c/o 2022              While the focus over the last year has been fixated on the deadly coronavirus, the importance of a long-standing health pandemic exacerbated by salt intake cannot be overlooked. Hypertension, more commonly referred to as high blood pressure, is a medical…

Desmopressin Challenge for Von Willebrand’s Disease i...
June 1, 2021 - Featured , In the News / Politics

By: Oluwafemi Popoola, PharmD Candidate c/o 2021, SUNY Binghamton School of Pharmacy & Pharmaceutical Sciences              A patient with past medical history of von Willebrand’s disease (VWD) and myasthenia gravis on chronic prednisone therapy, presented for follow-up for VWD at the hematology/oncology clinic. The provider considered having the patient undergo a “desmopressin challenge” with desmopressin…

Emerging Frontiers in Multiple Myeloma Pharmacotherapy...
June 1, 2021 - Clinical , Featured

By: Nishanth Viswanath, PharmD Candidate c/o 2022              Multiple myeloma (MM)  is a hematological malignancy characterized by an accumulation and proliferation of monoclonal plasma cells in the bone marrow. 1 Throughout the course of the disease, malignant plasma cells induce an overproduction of non-functional immunoglobulin (paraproteins), which is evident during urine and blood screenings. 2…

FDA approves Vibegron (Gemtesa®) for the Treatment of ...
June 1, 2021 - Featured , In the News / Politics

By: Arya Firoozan, PharmD Candidate c/o 2023              Overactive bladder (OAB) is a condition that causes a sudden and frequent urge to urinate. It is also associated with incontinence and nocturia. Nocturia refers to waking up at night due to the urge to urinate. OAB is diagnosed if there is no other current infection or…

Pharmaceutical Breakthrough for the Treatment of Duchen...
June 1, 2021 - Featured , In the News / Politics

By: Rubab Hassan, PharmD Candidate c/o 2022              Duchenne muscular dystrophy (DMD) is a genetic disorder that causes muscle degeneration and weakness along with various other symptoms. It is predominantly caused by deletions of one or more exons, which lead to mutations of the dystrophin gene. Dystrophin stops muscle fibers from being degraded by proteases.…



Do You Want to be a Published Author? Submit your Article(s) Today!



Tweets by @RhoChiPost

HOME: Home Page

VOLUMES / ISSUES: 14 . 13 . 12 . 11 . 10 . 9 . 8 . 7 . 6 . 5 . 4 . 3 . 2 . 1

ARTICLES: Featured . In the News / Politics . Events . Clinical . Advice / Opinions . Puzzles

FOR AUTHORS: Guidelines . AMA Citation Generator . Sign Up . Suggest . Submit . Cite

ABOUT US: About the Rho Chi Post . The Editorial Team . Apply for a Position

SUBSCRIBE: Google Groups Email List


Copyright © 2011-2025 Rho Chi Post